Prevalence of obesity and cardiovascular disease in adults with type 2 diabetes and use of diabetes medication in Germany: A claims data study
In this retrospective claims database study, more than two thirds of patients with T2D also had CVD, obesity, or both CVD and obesity. GLP-1 RA and SGLT2 inhibitor use remained low.
Authors
- Sven W. Görgens (ORCID: https://orcid.org/0000-0002-5676-3731)
- Lena M. Richter
- Dennis Häckl (ORCID: https://orcid.org/0000-0001-8542-693X)
- Nora Hennies (ORCID: https://orcid.org/0009-0001-3274-2055)
- Dirk Müller‐Wieland (ORCID: https://orcid.org/0000-0002-8807-6442)
- Thorsten Otto (ORCID: https://orcid.org/0009-0007-1928-8162)
- Jonas Killer
Institutions
- Eli Lilly (Germany) (DE)
- RWTH Aachen University (DE)
- Leipzig University (DE)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2024-09-19
- DOI
- https://doi.org/10.1111/dom.15931
- Citations
- 2
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.72
Funders
- Eli Lilly and Company